Parallel randomized controlled trial for Shengyang Yiwei Granule in the treatment of early Parkinson's disease
Phase 1
Recruiting
- Conditions
- parkinson disease
- Registration Number
- ITMCTR1900002593
- Lead Sponsor
- Kaida Wang
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
(1) Those who meet the diagnostic criteria of PD Chinese and Western medicine;
(2) TCM syndrome differentiation belongs to spleen and lung deficiency;
(3) Those aged 55-80 years;
(4) Modified HY stage <= 2.5;
(5) Conscious, vital signs are stable;
(6) Those who voluntarily accept this experimental study and informed consent.
Exclusion Criteria
(1) Parkinson's syndrome and Parkinson's superposition syndrome caused by various causes such as cerebrovascular disease and poisoning;
(2) Those with major diseases such as severe liver and kidney, blood, tumor, endocrine disease or pain
(3) Those who are involved in other drug clinical trials;
(4) Psychiatric patients;
(5) Those who have a history of ugly drinking or a history of drug abuse.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Parkinson's Non-motor syndrome Scale (NMSS);Unified Parkinson's Disease Rating Scale (UPDRSI II III);
- Secondary Outcome Measures
Name Time Method